Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis

• Market Cap: ¥14.41B
• Dividend Yield: 2.74%
• Average Volume (3M): 50.32K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.57
• Revenue Growth: 8.35%
• EPS Growth: -136.31%
• Country: JP
• Employees: 511
• Sector: Healthcare
• Sector Strength: 59
• Industry: Medical - Devices
• EPS (TTM): -50.93
• Shares Outstanding: 26,475,880
• 10 Day Avg. Volume: 43,560
• 30 Day Avg. Volume: 50,320
• PEG Ratio: -0.58
• Price to Book (P/B): 1.18
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 31.51
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 55 Neutral
• Price Target: ¥561.00 ▲(2.56%Upside)

The overall stock score is predominantly influenced by financial performance and technical analysis. Financial stability is a positive aspect, but profitability challenges and liquidity concerns are significant risks. Technical indicators suggest a neutral market sentiment, while the valuation is negatively impacted by recent losses. Despite a reasonable dividend yield, the negative P/E ratio remains a concern for potential investors.

Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model

Company Description

Japan Medical Dynamic Marketing, Inc. (7600) is a Japanese company that operates in the medical equipment sector. It is primarily engaged in the development, manufacturing, and distribution of orthopedic products and related medical devices. The company's core offerings include surgical instruments, implants for orthopedic surgery, and other medical apparatus designed to support healthcare providers in delivering high-quality patient care.

How the Company Makes Money

Japan Medical Dynamic Marketing, Inc. generates revenue through the sale of its medical devices and orthopedic products to hospitals, clinics, and other healthcare facilities. The company has a diverse product portfolio that includes implants, surgical instruments, and various medical devices, which are distributed through a robust sales network. Key revenue streams include direct sales to healthcare institutions and partnerships with medical distributors. Additionally, the company may engage in strategic partnerships or collaborations to enhance its product offerings and expand its market reach, contributing to its overall earnings.

Japan Medical Dynamic Marketing, Inc. Financial Statement Overview

Summary

Japan Medical Dynamic Marketing, Inc. shows stable revenue growth but faces challenges with profitability as seen in the negative net income in 2025. The balance sheet remains robust with low leverage, but cash flow management is an area of concern due to negative free cash flow. Continued focus on cost management and improving cash flow will be crucial for future financial health.

Income Statement

The company experienced a moderate revenue growth rate over recent years, with a notable increase from 2024 to 2025. However, the net profit margin turned negative in 2025, indicating profitability challenges. Gross profit margins have remained relatively stable, but declining EBIT and EBITDA margins suggest rising operational costs.

Balance Sheet

The balance sheet shows a strong equity base with a healthy equity ratio, demonstrating financial stability. The debt-to-equity ratio is relatively low, indicating conservative leverage. However, a decrease in stockholders' equity in 2025 could be a concern if it continues.

Cash Flow

Free cash flow has fluctuated, turning negative in 2025, which might impact liquidity. The operating cash flow to net income ratio shows adequate cash conversion, but the negative free cash flow raises concerns about the company's ability to fund operations and growth without external financing.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
24.64B	25.11B	23.18B	21.31B	19.19B	16.74B
	Gross Profit
14.93B	14.21B	14.76B	13.99B	12.99B	11.42B
	EBIT
1.79B	1.56B	1.75B	2.02B	2.66B	2.17B
	EBITDA
3.25B	1.40B	3.27B	3.35B	4.21B	3.47B
	Net Income Common Stockholders
1.42B	-461.80M	1.27B	1.42B	2.14B	1.66B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.33B	3.18B	2.32B	2.80B	2.59B	2.47B
	Total Assets
33.80B	33.67B	31.49B	29.43B	27.34B	25.19B
	Total Debt
2.71B	3.29B	1.49B	1.87B	1.85B	3.09B
	Net Debt
381.40M	104.19M	-827.12M	-933.23M	-742.10M	623.06M
	Total Liabilities
7.00B	8.93B	5.88B	6.14B	5.85B	6.48B
	Stockholders Equity
26.70B	24.68B	25.51B	23.16B	21.39B	18.63B
Cash Flow		Free Cash Flow
0.00	-504.10M	302.45M	870.67M	1.53B	1.23B
	Operating Cash Flow
0.00	1.05B	2.10B	2.19B	3.11B	2.60B
	Investing Cash Flow
0.00	-1.67B	-1.80B	-1.48B	-1.75B	-1.35B
	Financing Cash Flow
0.00	1.49B	-840.71M	-514.78M	-1.29B	-1.31B

Japan Medical Dynamic Marketing, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 547.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 547 is below the 20-day moving average (MA) of 551.75, above the 50-day MA of 542.68, and below the 200-day MA of 607.82, indicating a neutral trend. The MACD of 3.81 indicates Negative momentum. The RSI at 47.12 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.

Japan Medical Dynamic Marketing, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7963	81 Outperform	¥8.58B	10.25		2.04%	11.24%	53.32%
5187	78 Outperform	¥8.64B	8.41		4.21%	4.59%	1130.01%
7792	77 Outperform	¥12.07B	9.54		2.25%	13.54%	78.47%
6678	74 Outperform	¥15.81B	12.79		3.67%	5.92%	8.59%
7600	55 Neutral	¥14.41B	10.23		2.74%	8.35%	-136.31%
7777	54 Neutral	$23.16B	―	-184.59%	―	78.18%	35.77%
Sector *	54 Neutral	$5.38B	3.27	-45.10%	3.30%	16.81%	0.02%

Japan Medical Dynamic Marketing, Inc. Corporate Events

Japan Medical Dynamic Marketing Reports Financial Discrepancy for Fiscal Year 2025

Japan Medical Dynamic Marketing, Inc. reported a discrepancy between its forecasted and actual financial results for the fiscal year ending March 2025. The company experienced a larger than expected net loss due to the decision not to recognize deferred tax assets related to litigation settlement expenses. However, it anticipates recognizing these tax effects in the next fiscal year, potentially improving future financial outcomes.

Japan Medical Dynamic Marketing Reports Fiscal Year 2025 Financial Results

Japan Medical Dynamic Marketing, Inc. reported its financial results for the fiscal year ending March 2025, showing an 8.4% increase in net sales to ¥25,114 million. However, the company faced a decline in operating and ordinary profits, and a net loss attributable to owners of the parent. The capital adequacy ratio decreased to 73.3%, and cash flow from operating activities also declined. The company plans to increase its annual dividend to ¥15.00 per share, reflecting a cautious yet optimistic outlook for the upcoming fiscal year.